Anika Therapeutics Inc
Anika Therapeutics Inc (ANIK) Covered Calls
As of September 29, 2026, ANIK has 2 covered call opportunities in the coming three months. Return ranges from 13.6 to 47.5% until expiration. Annualized return ranges from 28.5 to 99.1%. The nearest expiration is March 19, 2027. Maximum potential profit is $968.
Read more
Running ANIK covered calls helps you generate consistent income from Anika Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Anika Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ANIK covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ANIK stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ANIK covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Anika Therapeutics Inc covered call is worth writing.
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products.
The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Income-focused investors, long-term ANIK holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ANIK covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Anika Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile21.83% Subdued
- Market cap (M$)267
- 52 weeks high-12.85%
- 52 weeks low129.99%
- Analyst recommendationStrong Buy
1.00 - Target price$22.00
10.33% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E20.99
- EPS (ttm)-0.27
- EPS growth next 5 years118.66%
As of September 29, 2026
| 2027-03-19 | 175 | 30.00 | 47.28 | 0.05 | 0.55 | 968.00 | 47.52 | 99.11 | -0.25 | +0.12 | 30 | 0.50 |
| 2027-03-19 | 175 | 22.50 | 10.46 | 0.65 | 2.30 | 278.00 | 13.65 | 28.46 | -3.19 | +0.43 | 15 | 1.65 |
As of September 29, 2026
Sell covered calls with the data behind you
Find the best ANIK covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→